Combined Liposuction and Physiologic Treatment Achieves Durable Limb Volume Normalization in Class II–III Lymphedema

医学 吸脂 淋巴水肿 蜂窝织炎 阶段(地层学) 外科 内科学 癌症 乳腺癌 古生物学 生物
作者
Philip S. Brazio,Dung Nguyen
出处
期刊:Annals of Plastic Surgery [Ovid Technologies (Wolters Kluwer)]
卷期号:86 (5S): S384-S389 被引量:36
标识
DOI:10.1097/sap.0000000000002695
摘要

Introduction Outcomes of surgical lymphedema treatment are currently suboptimal. Physiologic procedures including lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT) reestablish lymphatic flow but cannot correct fibroadipose deposition, whereas liposuction alone cannot prevent disease progression. We propose a treatment algorithm combining liposuction with LVA or VLNT that can achieve normal limb volumes and prevent disease progression in stage II–III lymphedema. Methods We performed a retrospective chart review of patients undergoing liposuction and physiologic lymphedema operations at our institution between January 2016 and June 2019. Patients were assigned to treatment groups according to their clinical presentation: physiologic first, followed by no further treatment (physiologic only) or liposuction (physiologic then liposuction); liposuction then physiologic; or simultaneous. Preoperative patient characteristics and sequence of operations were recorded. Compression garment usage was self-reported. Limb volumes were approximated as a truncated cone. Results Twenty-one patients met the inclusion criteria. The liposuction then physiologic group had significantly higher stage and excess limb volume at baseline, whereas the physiologic first groups had lower excess volume. While the physiologic only group had predominantly stage I disease, the patients who later required liposuction ( physiologic then liposuction group) all had stage II disease. All groups achieved 82% to 106% mean excess volume reduction, and volume reduction was maintained for up to 2.4 years. Compression garment class was not reduced, but mean postoperative compression duration decreased from 12.5 to 7.5 h/d ( P = 0.003). Ten of 11 patients with history of cellulitis had no further recurrence. Conclusion Lymphedema represents a continuum of fluid and fibroadipose disease. Accurate staging and timely treatment with physiologic procedures and liposuction can normalize limb volume. We propose a treatment algorithm to optimize outcomes. Patients with predominantly nonpitting presentation benefit from liposuction to maximize removal of fibroadipose tissue and optimize postoperative compression, followed by LVA or VLNT to improve lymphatic drainage. Patients with primarily pitting edema are best treated with physiologic procedures initially, reserving selective liposuction as a second stage. Patients with mixed presentation are best served by single-stage combination procedures.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
结实山水完成签到 ,获得积分10
1秒前
爆米花应助流窜意识采纳,获得10
1秒前
钟小熊完成签到,获得积分10
2秒前
3秒前
Heinrich完成签到,获得积分10
3秒前
yk完成签到 ,获得积分10
5秒前
善学以致用应助崽崽纯采纳,获得10
5秒前
5秒前
袜子关注了科研通微信公众号
6秒前
6秒前
炙热灵枫发布了新的文献求助10
7秒前
holly发布了新的文献求助50
9秒前
9秒前
小小学术人完成签到,获得积分10
10秒前
pluto应助ang采纳,获得10
11秒前
11秒前
量子星尘发布了新的文献求助10
12秒前
牛的滑完成签到,获得积分10
12秒前
Owen应助bodao采纳,获得10
13秒前
13秒前
13秒前
田様应助yjy123采纳,获得10
14秒前
被风吹过的路完成签到,获得积分10
14秒前
向阳而生完成签到,获得积分10
15秒前
大方忆秋完成签到 ,获得积分10
16秒前
18秒前
18秒前
LXL驳回了orixero应助
19秒前
NiNi完成签到 ,获得积分10
19秒前
不晚完成签到,获得积分20
20秒前
20秒前
fffff发布了新的文献求助10
22秒前
Mangues驳回了EchoH应助
22秒前
阿冲发布了新的文献求助10
23秒前
24秒前
xyu完成签到,获得积分10
24秒前
liu发布了新的文献求助10
24秒前
24秒前
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Ägyptische Geschichte der 21.–30. Dynastie 2500
Human Embryology and Developmental Biology 7th Edition 2000
The Developing Human: Clinically Oriented Embryology 12th Edition 2000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
„Semitische Wissenschaften“? 1510
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5741788
求助须知:如何正确求助?哪些是违规求助? 5404183
关于积分的说明 15343341
捐赠科研通 4883301
什么是DOI,文献DOI怎么找? 2625012
邀请新用户注册赠送积分活动 1573824
关于科研通互助平台的介绍 1530761